| Assessment Status | Assessment Process Complete |
| HTA ID | - |
| Drug | Nalmefene |
| Brand | Selincro® |
| Indication | Is indicated for the reduction of alcohol consumption in those aged ≥18 years with alcohol dependence, who do not require immediate detoxification. |
| Assessment Process | |
| Rapid review commissioned | 07/06/2013 |
| Rapid review completed | 28/06/2013 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Recommended |
| Full submission received from Applicant | 21/10/2013 |
| NCPE assessment completed | 08/04/2014 |
| NCPE assessment outcome | Reimbursement Recommended |
The NCPE consider this to be a cost effective product for the defined patient population in combination with psychosocial intervention.
